Dr. Annalise Rahman-Filipiak
Claim this profileStudies Alzheimer's Disease
Studies Mild Cognitive Impairment
1 reported clinical trial
2 drugs studied
More about Annalise Rahman-Filipiak
Clinical Trial Related2 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Annalise Rahman-Filipiak has experience with
- Biomarker Disclosure Protocol
- Diagnostic Disclosure Protocol
Breakdown of trials Annalise Rahman-Filipiak has run
Alzheimer's Disease
Mild Cognitive Impairment
Cognitive Disorder
Mild memory loss
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Annalise Rahman-Filipiak specialize in?
Annalise Rahman-Filipiak focuses on Alzheimer's Disease and Mild Cognitive Impairment. In particular, much of their work with Alzheimer's Disease has involved treating patients, or patients who are undergoing treatment.
Is Annalise Rahman-Filipiak currently recruiting for clinical trials?
No, Annalise Rahman-Filipiak is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Annalise Rahman-Filipiak has studied deeply?
Yes, Annalise Rahman-Filipiak has studied treatments such as Biomarker Disclosure Protocol, Diagnostic Disclosure Protocol.
What is the best way to schedule an appointment with Annalise Rahman-Filipiak?
Apply for one of the trials that Annalise Rahman-Filipiak is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.